Expression of RECK and matrix metalloproteinase-2 in ameloblastoma

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Zhang, Bin ^a   Zhang, Jin ^a   Xu, Zhi Ying ^a   Xie, Hong Liang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GELATINASE A; MESSENGER RNA; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; RECK PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AMELOBLASTIC CARCINOMA; AMELOBLASTOMA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOCYSTIC ODONTOGENIC TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ODONTOGENIC TUMOR; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN MOTIF; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; BIOSYNTHESIS; JAW TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 73149087678     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-427     Document Type: Article

References (20)

1. Luo HY, Li TJ. Odontogenic tumors: A study of 1309 cases in a Chinese population. Oral Oncol 2009, 45:706-711. 10.1016/j.oraloncology.2008.11.001, 19147397.
2. Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP. Ameloblastoma. Am J Clin Oncol 2007, 30:645-648. 10.1097/COC.0b013e3181573e59, 18091060.
3. Kumamoto H, Yamauchi K, Yoshida M, Ooya K. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 2003, 32:114-120. 10.1034/j.1600-0714.2003.00086.x, 12542835.
4. Wang A, Zhang B, Huang H, Zhang L, Zeng D, Tao Q, Wang J, Pan C. Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro. BMC cancer 2008, 8:182. 10.1186/1471-2407-8-182, 2443806, 18588710.
5. Zhang B, Zhang J, Huang HZ, Chen WL, Tao Q, Zeng DL, Zhang LT, Xu JH. Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity. J Oral Pathol Med 2009, 38:731-736. 10.1111/j.1600-0714.2009.00771.x, 19473446.
6. Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. J Orthop Res 2007, 25:696-702. 10.1002/jor.20323, 17262820.
7. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res 2003, 9:1779-1784.
8. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. The membrane-anchored MMP-inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001, 107:789-800. 10.1016/S0092-8674(01)00597-9, 11747814.
9. Eren B, Sar M, Oz B, Dincbas FH. MMP-2, TIMP-2 and CD44v6 expression in non-small-cell lung carcinomas. Ann Acad Med Singapore 2008, 37:32-39.
10. Wu CY, Wu MS, Chen YJ, Chen CJ, Chen HP, Shun CT, Chen GH, Huang SP, Lin JT. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer 2007, 43:799-808. 10.1016/j.ejca.2006.10.022, 17236757.
11. Baum O, Hlushchuk R, Forster A, Greiner R, Clézardin P, Zhao Y, Djonov V, Gruber G. Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit. Int J Oncol 2007, 30:325-332.
12. Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 2004, 45:65-72. 10.1111/j.1365-2559.2004.01902.x, 15228445.
13. Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clinl Cancer Res 2004, 10:5572-5579.
14. Mori T, Moriuchi R, Okazaki E, Yamada K, Katamine S. Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region. Biochem Biophys Res Commun 2007, 355:937-943. 10.1016/j.bbrc.2007.02.051, 17328864.
15. Kumamoto H, Ooya K. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors. J Oral Pathol Med 2006, 35:345-351. 10.1111/j.1600-0714.2006.00432.x, 16762015.
16. Wang Y, Xu HT, Ueda Y, Shimasaki M, Wang EH. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours. Pathology 2007, 39:486-490. 10.1080/00313020701569964, 17886098.
17. Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol 2007, 42:120-128. 10.1007/s00535-006-1975-y, 17351800.
18. Yeh MW, Rougier JP, Park JW, Duh QY, Wong M, Werb Z, Clark OH. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. Endocr Relat Cancer 2006, 13:1173-1783. 10.1677/erc.1.01226, 2574514, 17158762.
19. Schwandner O, Schlamp A, Broll R, Bruch HP. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. Int J Colorectal Dis 2007, 22:127-136. 10.1007/s00384-006-0173-y, 16896992.
20. Yoshida D, Nomura R, Teramoto A. Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). J Neurooncol 2008, 89:141-150. 10.1007/s11060-008-9606-5, 18493720.